Acuite upgrades credit ratings of Bal Pharma

22 Feb 2022 Evaluate

Credit rating agency -- Acuite has upgraded credit ratings of Bal Pharma. Long Term Fund based facilities has been upgraded to ‘BBB-’ stable from ‘BB+’ positive. Short term Non fund based facilities has been upgraded to ‘A3’ from ‘A4+’. Also, Long term-Term Loan has been upgraded to ‘BBB-’ stable from ‘BB+’ positive.

Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Bal Pharma Share Price

71.75 -2.82 (-3.78%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×